Angiopep-2|TFFYGGSRGKRNNFKTEEYC|TAT|YGRKKRRQRRRC
- Liven Qian
- Oct 29, 2018
- 1 min read
Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides
文献作者:Yaqin Zhu, Yu Jiang, Fenghua Meng, Chao Deng, Ru Cheng, Jian Zhang, Jan Feijen, Zhiyuan Zhong 《Journal of Controlled Release》
ABSTRACTS
Glioma is a highly challenging human malignancy as drugs typically exhibit a low blood-brain barrier (BBB) permeability as well as poor glioma selectivity and penetration. Here, we report that tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides, Angiopep-2 and TAT, enable a highly efficacious and specific anti-glioma chemotherapy. Interestingly, tandem nanomicelles with 20?mol% Angiopep-2 and 10?mol% TAT linked via long and short poly(ethylene glycol)s, respectively, while maintaining a high glioma cell selectivity display markedly enhanced BBB permeation, glioma accumulation and penetration, and glioma cell uptake. We further show that docetaxel-loaded tandem nanomicelles have a long blood circulation time in mice and significantly better inhibit orthotopic U87MG human glioma than the corresponding Angiopep-2 single peptide-functionalized control, leading to an improved survival rate with little adverse effects. These tandem nanomicelles uniquely combining brain tumor-targeting and cell-penetrating functions provide a novel and effective strategy for targeted glioma therapy.
Graphical abstract

KEY WORDS
Nanomicelles; Reduction-sensitive; Glioma; TAT; Blood-brain barrier.
SCREENSHOT

RELATED PRODUCTS
Angiopep-2 (ANG, 95%, TFFYGGSRGKRNNFKTEEYC) and TAT (98%, YGRKKRRQRRRC) (ChinaPeptides Co., Ltd., Shanghai, China)
CHAINING
https://www.sciencedirect.com/science/article/pii/S016836591830155X


Comments